Toronto, Canada Clinical Trials

test12 (test12)

test12

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine  

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

Women's College Hospital

 (0.6 away)

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

A Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM).

University Health Network (UHN) - Princess Margaret Cancer Centre (Princess Margaret Hospital)

 (0.5 away) Contact site

Test Reassign  

Test Reassign

Second Site

 (5.7 away)

Verify Reassign Case  

Verify Reassign Case

Case B Site 2

 (5.2 away)

New Study  

S2

 (8.0 away)

Cookie Testing  

Cookie Testing

Site

(online study)

RJ_StudyVirtualF  

Acne

Site1_RJ_StudyVirtual1N

(online study)

T2

we

8260013

(online study) Contact site

A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707)  

Primary Objectives:Evaluate the safety and tolerability of THOR-707 as a single agent and as a combination therapy (identify Dose Limiting Toxcitiy (DLTs) in Cohorts A, B, C, D, and G, and adverse events (AEs)/serious adverse event (SAE) profile in Cohorts A, B, C, D, E, F, and G)Define the Maximium …

Formal Site

(online study)